23/10/2024
M&C Decisions’ Addressing Project Optimus: Preclinical data and modeling support identification of the Recommended Phase 2 Dose for saruparib was presented at the 36th EORTC-NCI-AACR SYMPOSIUM on 23-25 October, Barcelona, Spain. Authors: A. Staniszewska, E. Lukacs, G. Moorthy, V. Veronova, K. Peskov, S. Linardopoulos, K. Sugibayashi, C. Wilks, H. Kimko, S. Cosulich, M. Albertella.
